OR WAIT 15 SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
Rathin Das, PhD, MBA, is chief executive officer of Synergys Biotherapeutics, 1945 Arbol Grande, Walnut Creek, CA 94595, email@example.com
The authors review the angiopoietin pathway as an alternative for safer and more efficacious anti-angiogenic therapeutics.
Innovative products and a range of indications drive the therapeutic antibody market.